Dergiler / Middle Black Sea Journal of Health Science / 2018 / Cilt: 4 - Sayı: 2

Investigation of Serum Brain Derived Neurotrophic Factor Levels in Children and Adolescents Aged 12 to 18 Years with Depressive Disorder

Sayfa
1–6
Yayın Tarihi
2018-08-30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

But larger prospective studies are needed to show better the effects of these factors.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: It has been suggested that the neuroplastic processis associated with the pathogenesis of psychiatric disorders including depressive disorder.
📊
Temel Bulgular & Veri:Insulin like growth factor-1 (IGF-1) is found in various areas of the brain.
💡
Sonuç & Katkı:But larger prospective studies are needed to show better the effects of these factors.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Brain derived neurotrophic factor · insulin-like growth factor-1 · depression

Abstract

Objective: It has been suggested that the neuroplastic processis associated with the pathogenesis of psychiatric disorders including depressive disorder. It is thought that brain derived neurotrophic factor (BDNF) is an important factor in neuroplasticity in depressive disorder. BDNF is play an important role in survival of neurons, synaptic plasticity, formation of synaptic connections and neurodevelopment. Insulin like growth factor-1 (IGF-1) is found in various areas of the brain. IGF-1 is involved in brain growth, development and mylination, also in brain plasticity. IGF-1 affect the genesis of neurons, astrocytes, oligodendrocytes and endothelial cells. In this study we aimed to evaluate serum levels of BDNF and IGF-1, which is also accepted as a neurotrophic factor, in children and adolescents between 12-18 years with depressive disorder. Methods: The patient group was composed of 35 subjects (26 females; 9 male), while the control group was composed of 22 subjects (14 females; 8 male). Sociodemographic form, Kovac’s depression scale, and state-trait anxiety inventory were applied to all subjects. Serum BDNF and IGF-1 levels were measured with ELISA. Moreover complete blood count, biochemical tests, thyroid and sex hormones were tested.Results: There was no significant difference between the patient group and the control group in terms of the BDNF and IGF-1 levels (respectively p values 0.547 and 0.968). When the groups divided into female and male subgroups, statistically significant differences were not found again. Moreover age, gender, menstrual states, suicide attempts, suicide thoughts, smoking and Body Mass Index had no effects on the BDNF. There was also no effects on IGF-1 levels, except age. There was negative correlation between age and IGF-1 in all subjects.Conclusion: The results of this study do not support the association of depressive disorder with changes in serum BDNF and IGF-1 levels in children and adolescents. But larger prospective studies are needed to show better the effects of these factors.

🔖

Bu Makaleye Atıf Yap

ESNAFOGLU, E., TANELİ, Y., KIRHAN, E., Dirican, M. (2018). Investigation of Serum Brain Derived Neurotrophic Factor Levels in Children and Adolescents Aged 12 to 18 Years with Depressive Disorder. Middle Black Sea Journal of Health Science, Cilt: 4 - Sayı: 2, 1–6. https://ajindex.com/articles/791210

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry, 2006:59:673-80
  2. Park RJ, Goodyer IM. Clinical guidelines for depressive disorders in childhood and adolescence. Eur Child Adolesc Psychiatry, 2000:9:147-61
  3. Birmaher B, Brent D. Practice parameters for the assessment and treatment of children and adolescent with depressive disorder. J Am Acad Child Adolesc Psychiatry, 1998:37:63-83
  4. Herken H. Depresyon etyolojisinde genetik kanıtlar. Klinik psikiyatri. 2002:4:5-10
  5. Uzbay İT. Nöroplastisite ve Depresyon. 1. baskı. Ankara: Çizgi Tıp yayınevi, 2005
  6. Tapia-Arancibia L, Rage F, Givalois L and Aracibia S. Physiology of BDNF: focus on hypothalamic function. Front in Neuroendocrinol, 2004:25:77-107
  7. Aydemir Ö, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progr Neuro-Psychopharmacol Biol Pschiatry, 2005:29:261-5
  8. Kalueff AV, Wheaton M, Ren-Patterson R, Murphy DL. Brain-derived neurotrophic factor, serotonin transporter, and depression: comment on Kaufman et al. Biological psychiatry, 2007:61:1112-1113
  9. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research Reviews, 2004:45:104-14
  10. Katoh-Semba R, Wakako R, Komari T et al. Age-related changes in BDNF levels in human serum: differences between autism cases and normal control. Int J Dev Neuroscience, 2007:25:367-72
  11. McCusker RH, McCrea K, Zunich S, Dantzer R, Broussard SR, Johnson RW et al.Insuline-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocorticalneurons. J Neuroimmunol, 2006:179:186-90
  12. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol, 2007:18:391-418
  13. Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-1 and BDNF leads to long-lasting antidepressant-like effects. Brain Res, 2005:1037: 204-8
  14. Öy B. Çocukluk Depresyonu Derecelendirme Ölçeği: Sağlıklı ve Çocuk Ruh Sağlığı Kliniğine Başvuran Çocuklarda Uygulanması. Türk Psikiyatri Dergisi, 1991:2:137-40
  15. Öner N, Le Compte A (ed). Süreksiz durumluluk/ sürekli kaygı envanteri el kitabı. İk